Advanced search
Publication Cover
Acta Cardiologica Volume 62, 2007 - Issue 5
Submit an article Journal homepage
3
Views
1
CrossRef citations to date
0
Altmetric
Articles

Heart fatty acid binding protein and myoglobin after reperfusion of acute myocardial infarction

Murat ÖzdemirDepartment of Cardiology, Gazi University School of Medicine, Ankara, Turkey.Correspondence[email protected]
,
Emre DurakoglugilDepartment of Cardiology, Gazi University School of Medicine, Ankara, Turkey.
,
Özlem GülbaharDepartment of Biochemistry, Gazi University School of Medicine, Ankara, Turkey.
,
Sedat TurkogluDepartment of Cardiology, Gazi University School of Medicine, Ankara, Turkey.
,
Banu SancakDepartment of Biochemistry, Gazi University School of Medicine, Ankara, Turkey.
,
Hatice PaşFaogluDepartment of Biochemistry, Gazi University School of Medicine, Ankara, Turkey.
&
Atiye ÇengelDepartment of Cardiology, Gazi University School of Medicine, Ankara, Turkey.
 show all
Pages 473-478 | Received 09 May 2007, Accepted 11 Jul 2007, Published online: 23 May 2017

References

  • Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Jr., Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82–292.
  • Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexan-der B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879–88.
  • Azzazy HM, Pelsers MM, Christenson RH. Unbound free fatty acids and heart-type fatty acid-binding protein: diag-nostic assays and clinical applications. Clin Chem 2006; 52: 19–29.
  • Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding pro-teins as plasma markers of tissue injury. Clin Chim Acta 2005; 352: 15–35.
  • Ishii J, Wang JH, Naruse H, Taga S, Kinoshita M, Kurokawa H, Iwase M, Kondo T, Nomura M, Nagamura Y, Watanabe Y, Hishida H, Tanaka T, Kawamura K. Serum concentrations of myoglobin vs. human heart-type cyto-plasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997; 43: 1372–8.
  • Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asayama K, Kimura H, Nishimura S, Ishii H, Sunahara N, Tanaka T. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myo-globin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000; 38: 231–8.
  • Seino Y, Tomita Y, Takano T, Ohbayashi K. Office cardiol-ogists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: com-parison between heart-type fatty acid-binding protein and troponin T tests. Circ J2004; 68: 144–8.
  • Haastrup B, Gill S, Kristensen SR, Jorgensen PJ, Glatz JF, Haghfelt T, Horder M. Biochemical markers of ischaemia for the early identification of acute myocardial infarction without ST segment elevation. Cardiology 2000; 94: 254–61.
  • Chan CP, Sanderson JE, Glatz JF, Cheng WS, Hempel A, Renneberg R. A superior early myocardial infarction marker. Human heart-type fatty acid-binding protein. Z Kardiol 2004; 93: 388–97.
  • Wodzig KW, Kragten JA, Modrzejewski W, Gorski J, van Dieijen-Visser MP, Glatz JF, Hermens WT. Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins. Clin Chim Acta 1998; 272: 209–23.
  • Alhadi HA, Fox KA. Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein. QJM 2004; 97: 187–98.
  • Rajappa M, Sharma A. Biomarkers of cardiac injury: an update. Angiology 2005; 56: 677–91.
  • Christenson RH, Ohman EM, Topol EJ, Peck S, Newby LK, Duh SH, Kereiakes DJ, Worley SJ, Alosozana GL, Wall TC, Calif RM. Assessment of coronary reperfusion after throm-bolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Throm-bolysis and Angioplasty in Myocardial Infarction-7. Circulation 1997; 96: 1776–82.
  • Stewart JT, French JK, Theroux P. Ramanathan K, Soly-moss BC, Johnson R, White HD. Early noninvasive identi-fication of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. J Am Coll Cardiol 1998; 31: 1499–505.
  • Tanasijevic MJ, Cannon CP, Antman EM, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Braunwald E. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. J Am Coll Cardiol 1999; 34: 739–47.
  • Laperche T, Steg PG, Benessiano J, Dehoux M, Juliard JM, Himbert D, Gourgon R. Patterns of myoglobin and MM creatine kinase isoforms release early after intravenous thrombolysis or direct percutaneous transluminal coronary angioplasty for acute myocardial infarction, and implica-tions for the early noninvasive diagnosis of reperfusion. Am J Cardiol 1992; 70: 1129–34.
  • de Groot MJ, Muijtjens AM, Simoons ML, Hermens WT, Glatz JF. Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma. Heart 2001; 85: 278–85.
  • de Lemos JA, Antman EM, Morrow DA, Llevadot J, Giugliano RP, Coulter SA, Schuhwerk KC, Arslanian S, McCabe CH, Gibson CM, Rifai N. Heart-type fatty acid binding protein as a marker of reperfusion after throm-bolytic therapy. Clin Chim Acta 2000; 298: 85–97.
  • Ishii J, Nagamura Y, Nomura M, Wang JH, Taga S, Kinoshita M, Kurokawa H, Iwase M, Kondo T, Watanabe Y, Hishida H, Tanaka T, Kawamura K. Early detection of successful coronary reperfusion based on serum concentra-tion of human heart-type cytoplasmic fatty acid-binding protein. Clin Chim Acta 1997; 262: 13–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.